This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bestewil Holding B.v.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Anke Luise Wilhelmine Huckriede: Innovator in Virosome Technology
Introduction
Anke Luise Wilhelmine Huckriede is a prominent inventor based in Haren, Netherlands. She has made significant contributions to the field of virosome technology, particularly through her innovative methods for producing virosome-like particles. Her work has implications for vaccine development and drug delivery systems.
Latest Patents
Anke Huckriede holds a patent for her invention titled "Virosome-like-particles." This invention relates to the production of virosome-like particles and provides a method for producing these particles by contacting an enveloped virus with a solution containing a short-chain phospholipid. This process allows for the solubilization of the viral envelope, followed by the removal of the short-chain phospholipid, resulting in the formation of a functionally reconstituted viral envelope. She has 1 patent to her name.
Career Highlights
Anke Huckriede is associated with Bestewil Holding B.V., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in the field of virosome technology.
Collaborations
Anke collaborates with notable colleagues, including Jørgen Martin De Jonge and Antonius Johannes Hendrikus Stegmann. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in virosome technology.
Conclusion
Anke Luise Wilhelmine Huckriede is a trailblazer in the field of virosome technology, with her innovative methods paving the way for future advancements in vaccine and drug delivery systems. Her contributions are invaluable to the scientific community and the ongoing development of medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile